Dataconomy
  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
Subscribe
No Result
View All Result
  • AI
  • Tech
  • Cybersecurity
  • Finance
  • DeFi & Blockchain
  • Startups
  • Gaming
Dataconomy
  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
Subscribe
No Result
View All Result
Dataconomy
No Result
View All Result

AI stethoscope spots 3 heart issues in 15 seconds

An AI-powered stethoscope can detect three serious heart conditions in seconds, now being tested across UK GP surgeries.

byEmre Çıtak
September 1, 2025
in Artificial Intelligence, Healthcare
Home News Artificial Intelligence

A new AI-powered stethoscope developed by Imperial College London and Imperial College Healthcare NHS Trust is being deployed in a nationwide study to detect three serious heart conditions within seconds.

The device, approximately the size of a playing card, is currently part of the TRICORDER study and identifies Heart Failure (HF), Atrial Fibrillation (AF), and Valvular Heart Disease (VHD). It integrates a single-lead ECG sensor and a microphone array to record phonocardiogram (PCG) waveforms. Algorithms interpret these readings to detect abnormalities. The device connects to a smartphone via Bluetooth, transmitting data to the cloud over Wi-Fi or cellular networks, capable of detecting heart issues in 15 seconds.

Classified as a Class IIa medical device, it is authorized for regular healthcare use, eliminating the need for patient consent from doctors and healthcare professionals. The device serves as a replacement stethoscope for routine clinical examinations by general practitioners (GPs) nationwide. Placed over the upper left sternal border area, it records for 15 seconds. The algorithms, governed by the UK Medicines and Healthcare Products Regulatory Agency (MHRA), have yielded promising results.

Stay Ahead of the Curve!

Don't miss out on the latest insights, trends, and analysis in the world of data, technology, and startups. Subscribe to our newsletter and get exclusive content delivered straight to your inbox.

A research paper published in the BMJ Open journal states, “The statistical performance of these three AI algorithms has been shown to be high and consistent against international external validation studies.” The initial study involved examinations of patients presenting with fatigue and breathlessness across 200 GP surgeries, covering over 1.5 million patients.

The British Heart Foundation, a partial funder of the studies, reported that patients examined with the AI-powered stethoscope were approximately 3.5 times more likely to be diagnosed with atrial fibrillation and almost twice as likely to receive a diagnosis of heart valve disease. This early detection aims to enable timely access to life-saving medications and treatments. Heart failure, affecting a million patients in the UK, is detected in 70 percent of cases only during emergency care.

Professor Nicholas Peters, senior investigator from Imperial College London and consultant cardiologist at Imperial College Healthcare NHS Trust, noted the smart stethoscope’s ability to detect three serious heart conditions in one sitting. Eko Health, a California-based company, manufactures the device.

The UK’s National Health Service (NHS) claims that implementing this tool in primary care could save the NHS £2,400 per patient by eliminating potential unplanned A&E visits. Over three million patients have enrolled in the TRICORDER trial program, with potential future healthcare savings exceeding one hundred million pounds for the government.

Featured image

Tags: AIFeaturedhealthcarestethoscope

Related Posts

AI boosts developer productivity, human oversight still needed

AI boosts developer productivity, human oversight still needed

September 2, 2025
ChatGPT logo fixes drive demand for graphic designers

ChatGPT logo fixes drive demand for graphic designers

September 2, 2025
Google trains Veo AI on YouTube videos, creators object

Google trains Veo AI on YouTube videos, creators object

September 2, 2025
Meta AI bots used celebrity likenesses without consent

Meta AI bots used celebrity likenesses without consent

September 2, 2025
xAI sues former engineer to stop him from joining OpenAI, alleging theft of Grok trade secrets

xAI sues former engineer to stop him from joining OpenAI, alleging theft of Grok trade secrets

September 2, 2025
Psychopathia Machinalis and the path to “Artificial Sanity”

Psychopathia Machinalis and the path to “Artificial Sanity”

September 1, 2025

LATEST NEWS

UK Home Office seeks full Apple iCloud data access

iPhone 17 may drop physical SIM in EU

Zscaler: Salesloft Drift breach exposed customer data

AI boosts developer productivity, human oversight still needed

Windows 11 25H2 enters testing with no new features

ChatGPT logo fixes drive demand for graphic designers

Dataconomy

COPYRIGHT © DATACONOMY MEDIA GMBH, ALL RIGHTS RESERVED.

  • About
  • Imprint
  • Contact
  • Legal & Privacy

Follow Us

  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
No Result
View All Result
Subscribe

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy Policy.